Ocular Oncology

Top Story

Palladium-103 brachytherapy deemed safe, pupil-sparing treatment

April 17, 2017

Iris melanoma treated with palladium-103 plaque brachytherapy showed patterns of regression that included decreased intrinsic tumor vascularity, increased tumor pigmentation and decreased tumor thickness, according to a study.

Palladium-103 (Pd) ophthalmic plaque radiation therapy is used to treat iris melanoma by preserving normal iris tissue and function compared with less conservative treatment options: iridectomy, iridocyclectomy and enucleation.

Aura Biosciences’ ocular melanoma treatment receives fast track designation

April 3, 2017
AU-011, an investigational, first-in-class targeted therapy for ocular melanoma treatment, was granted fast track designation by the FDA, according to a press release…
Meeting NewsVideo

VIDEO: Effective therapies needed for uveal melanoma

March 30, 2017
NEW YORK — Some clinical trials evaluating standard melanoma immunotherapies have been disappointing for metastatic uveal melanoma, Alexander Shoushtari, MD,

Fine needle aspiration biopsy safe in uveal melanoma

March 21, 2017
A study carried out at Retina Consultants of Houston and Houston Methodist Hospital confirmed the safety of fine needle aspiration biopsy in patients with uveal…
Original Article

Prevalence, Incidence, and Risk Factors for the Development of Glaucoma in Patients With Aniridia

Journal of Pediatric Ophthalmology and Strabismus
Online Advanced Release, May 17, 2017
To assess the prevalence, incidence, and risk factors for the development of glaucoma in patients with aniridia…
More »
CME

Best of Retina Forum® 2016 - Diabetic Retinopathy: A Revolution in Treatment Options

This activity is supported by educational grants from Carl Zeiss Meditec, Inc. and Regeneron Pharmaceuticals, Inc.

Diabetic retinopathy (DR) is an insidious, progressive disease. Diabetic macular edema (DME), which can occur at any…
More »
Featured
Video
Meeting News

VIDEO: Effective therapies needed for uveal melanoma

March 30, 2017
More »

Palladium-103 brachytherapy deemed safe, pupil-sparing treatment

April 17, 2017
Iris melanoma treated with palladium-103 plaque brachytherapy showed patterns of regression that included decreased intrinsic tumor vascularity…

Aura Biosciences’ ocular melanoma treatment receives fast track designation

April 3, 2017
AU-011, an investigational, first-in-class targeted therapy for ocular melanoma treatment, was granted fast track designation by the FDA, according…

Meeting NewsVideo

VIDEO: Effective therapies needed for uveal melanoma

March 30, 2017
NEW YORK — Some clinical trials evaluating standard melanoma immunotherapies have been disappointing for metastatic uveal melanoma, Alexander

Fine needle aspiration biopsy safe in uveal melanoma

March 21, 2017
A study carried out at Retina Consultants of Houston and Houston Methodist Hospital confirmed the safety of fine needle aspiration biopsy in patients…

Meeting News

Speaker: Consider intraocular tumors before enucleation, evisceration

March 14, 2017
PHILADELPHIA — Imaging studies should be completed before enucleation or evisceration surgeries to rule out unsuspected tumors, a speaker said…

Meeting News

Fewer malignant conjunctival tumors seen in children

March 10, 2017
PHILADELPHIA – Conjunctival tumors in children statistically are more often benign than those in adults and can be differentiated by using a…

FDA News

FDA clears IND application for Aura Biosciences’ AU-011 for ocular melanoma

February 6, 2017
The FDA has cleared an investigational new drug application for light-activated AU-011 in ocular melanoma, allowing clinical testing to begin…

In the Journals

Study: Conjunctival tumors in children rarely malignant

February 3, 2017
In a study of cases spanning nearly 40 years, only 3% of conjunctival tumors in children were malignant. The retrospective case series analyzed the…

In the Journals PlusPerspective

Topotecan-based regimen improves ocular salvage, vision preservation in advanced retinoblastoma

December 2, 2016
The combination of systemic vincristine, topotecan and carboplatin with aggressive focal therapies improved ocular salvage and preserved vision in…

PUBLICATION EXCLUSIVE: Chemotherapy can suppress inflammatory signs of periocular filariasis

November 15, 2016
Dirofilaria repens is an endemic parasite in Mediterranean countries that mostly affects animals. Dirofilaria is a genus of the family Onchocercidae…

More Headlines »
Advertisement
Advertisement